LTR Pharma Ltd (ASX: LTP) - Share Price

- Current share price for LTP : $0.430

LTR Pharma Ltd (LTP) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in improving men's health, physically and mentally, through the commercialisation of an intranasal spray treatment for Erectile Dysfunction (ED).

LTP General Information ⁺

ASX Code	LTP
Website	N/A
Industry/Sector	Pharmaceuticals
Market Cap ($M)	78
LTP Share Price	$0.430
Day High	$0.440
Day Low	$0.405
Last Close	$0.430
LTP Share Price Movement	- ( No change )

Prices as at 16:40, 2 Nov 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

LTR Pharma Ltd (LTP) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from LTR Pharma Ltd (LTP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

LTR Pharma Ltd (LTP) price-sensitive announcements

LTP - Quarterly Activities/Appendix 4C Cash Flow Report

LTR Pharma Limited’s Quarterly Activities Report and Appendix 4C for the quarter ended 30

LTR Pharma Ltd (LTP)
28 Oct 2026 | 8:22 AM

LTP - First ROXUS Prescriptions Fulfilled in the United States

LTR Pharma Limited (ASX: LTP) announced that the first patient-specific ROXUS prescription

LTR Pharma Ltd (LTP)
6 Oct 2026 | 8:30 AM

LTP - SPONTAN Phase II Final Results

LTR Pharma announced that the final Clinical Study Report for its Phase II pharmacokinetic

LTR Pharma Ltd (LTP)
1 Oct 2026 | 8:24 AM

LTP - FY26 Results Announcement

LTR Pharma Ltd’s FY26 full-year results announcement outlines a transition from clinical d

LTR Pharma Ltd (LTP)
28 Aug 2026 | 7:48 AM

LTR Pharma Ltd (LTP) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	Quarterly Activities/Appendix 4C Cash Flow Report	28 Oct 2026 8:22AM	$0.440	$0.430	fallen by 2.27%
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	Results of Meeting	23 Oct 2026 5:04PM	$0.445	$0.430	fallen by 3.37%
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	AGM Presentation	23 Oct 2026 2:00PM	$0.460	$0.430	fallen by 6.52%
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	SPONTAN to be Evaluated in Pulmonary Arterial Hypertension	22 Oct 2026 8:24AM	$0.485	$0.430	fallen by 11.34%
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	SPONTAN passes 2,000 dispensed units in Australia	21 Oct 2026 8:44AM	$0.470	$0.430	fallen by 8.51%
LTR Pharma Ltd (LTP) ORDINARY FULLY PAID	Health Care	$78	Investor Webinar Presentation	6 Oct 2026 8:39AM	$0.495	$0.430	fallen by 13.13%

LTP Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$14.16	-$7.80	133.50%	0.00%	0.0%
2025A	-$5.59	-$3.30	-33.10%	0.00%	0.0%
2024A	-$6.95	-$5.00	379.80%	0.00%	0.0%

LTP Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Clarity Pharmaceuticals Ltd (CU6)	$586M	0.4454	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
LTR Pharma Ltd (LTP)	$78M	1.3353	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Neuren Pharmaceuticals Limited (NEU)	$2,581M	-0.7857	0.2462	0.9655	87.4946	70.2069	35.7193	0.00%	1.62%	1.92%

LTP Directors

Name	Position	Start Date
Mr Lee Rodne	Executive Chairman, Executive Director	7 Oct 2020
Dr Julian John Chick	Non-Executive Director	25 Nov 2020
Ms Maja Aleksandra McGuire	Non-Executive Director	6 Sep 2021

LTR Pharma Ltd (LTP) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value

See all changes in directors' interest & trades for LTR Pharma Ltd (LTP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

LTP Management

Name	Position
Euh(David) Hwang	Joint Company Secretary
Elizabeth Spooner	Joint Company Secretary

LTP Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in LTR Pharma Ltd (LTP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
46,373,750 (25.51%)	LTR Medical Pty Ltd

LTP Calendar of Events

Date	Event
27 August 2027	Report (Annual)
27 August 2027	Report (Prelim)
25 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us